Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

IBTA vs ACMR vs DSGX vs ICHR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IBTA
Ibotta, Inc.

Software - Application

TechnologyNYSE • US
Market Cap$1.04B
5Y Perf.-64.1%
ACMR
ACM Research, Inc.

Semiconductors

TechnologyNASDAQ • US
Market Cap$3.92B
5Y Perf.+132.0%
DSGX
The Descartes Systems Group Inc.

Software - Application

TechnologyNASDAQ • CA
Market Cap$6.31B
5Y Perf.-20.9%
ICHR
Ichor Holdings, Ltd.

Semiconductors

TechnologyNASDAQ • US
Market Cap$2.47B
5Y Perf.+83.7%

IBTA vs ACMR vs DSGX vs ICHR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IBTA logoIBTA
ACMR logoACMR
DSGX logoDSGX
ICHR logoICHR
IndustrySoftware - ApplicationSemiconductorsSoftware - ApplicationSemiconductors
Market Cap$1.04B$3.92B$6.31B$2.47B
Revenue (TTM)$340M$901M$731M$959M
Net Income (TTM)$-7M$94M$164M$-51M
Gross Margin78.4%44.4%71.4%11.3%
Operating Margin-2.6%12.1%30.4%-3.8%
Forward P/E305.9x29.7x39.3x62.2x
Total Debt$26M$303M$8M$186M
Cash & Equiv.$187M$766M$354M$98M

IBTA vs ACMR vs DSGX vs ICHRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IBTA
ACMR
DSGX
ICHR
StockApr 24May 26Return
Ibotta, Inc. (IBTA)10035.9-64.1%
ACM Research, Inc. (ACMR)100232.0+132.0%
The Descartes Syste… (DSGX)10079.1-20.9%
Ichor Holdings, Ltd. (ICHR)100183.7+83.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: IBTA vs ACMR vs DSGX vs ICHR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ACMR and DSGX are tied at the top with 3 categories each — the right choice depends on your priorities. The Descartes Systems Group Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. ICHR also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
IBTA
Ibotta, Inc.
The Secondary Option

IBTA lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
ACMR
ACM Research, Inc.
The Income Pick

ACMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 3 yrs, beta 3.24, yield 0.2%
  • Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
  • 30.7% 10Y total return vs ICHR's 6.3%
  • PEG 0.84 vs DSGX's 1.53
Best for: income & stability and growth exposure
DSGX
The Descartes Systems Group Inc.
The Defensive Pick

DSGX is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 0.71, Low D/E 0.5%, current ratio 2.16x
  • Beta 0.71, current ratio 2.16x
  • 22.5% margin vs ICHR's -5.3%
  • Beta 0.71 vs ICHR's 3.93, lower leverage
Best for: sleep-well-at-night and defensive
ICHR
Ichor Holdings, Ltd.
The Momentum Pick

ICHR is the clearest fit if your priority is momentum.

  • +329.1% vs DSGX's -31.7%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthACMR logoACMR15.2% revenue growth vs IBTA's -6.8%
ValueACMR logoACMRLower P/E (29.7x vs 62.2x)
Quality / MarginsDSGX logoDSGX22.5% margin vs ICHR's -5.3%
Stability / SafetyDSGX logoDSGXBeta 0.71 vs ICHR's 3.93, lower leverage
DividendsACMR logoACMR0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)ICHR logoICHR+329.1% vs DSGX's -31.7%
Efficiency (ROA)DSGX logoDSGX9.2% ROA vs ICHR's -5.2%, ROIC 14.9% vs -3.9%

IBTA vs ACMR vs DSGX vs ICHR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IBTAIbotta, Inc.
FY 2024
Breakage
100.0%$15M
ACMRACM Research, Inc.
FY 2025
Total Single Wafer and Semi-Critical Cleaning Equipment
69.5%$626M
ECP Front End And Packaging Furnace And Other Technologies
22.1%$200M
Advanced Packaging (exclude ECP), Services & Spares
8.4%$76M
DSGXThe Descartes Systems Group Inc.
FY 2025
Service
92.9%$677M
Professional services and other
6.8%$49M
License
0.3%$3M
ICHRIchor Holdings, Ltd.

Segment breakdown not available.

IBTA vs ACMR vs DSGX vs ICHR — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACMRLAGGINGICHR

Income & Cash Flow (Last 12 Months)

DSGX leads this category, winning 4 of 6 comparable metrics.

ICHR is the larger business by revenue, generating $959M annually — 2.8x IBTA's $340M. DSGX is the more profitable business, keeping 22.5% of every revenue dollar as net income compared to ICHR's -5.3%. On growth, DSGX holds the edge at +17.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
RevenueTrailing 12 months$340M$901M$731M$959M
EBITDAEarnings before interest/tax-$3M$126M$310M-$11M
Net IncomeAfter-tax profit-$7M$94M$164M-$51M
Free Cash FlowCash after capex$81M-$69M$261M-$17M
Gross MarginGross profit ÷ Revenue+78.4%+44.4%+71.4%+11.3%
Operating MarginEBIT ÷ Revenue-2.6%+12.1%+30.4%-3.8%
Net MarginNet income ÷ Revenue-2.1%+10.4%+22.5%-5.3%
FCF MarginFCF ÷ Revenue+23.8%-7.6%+35.8%-1.7%
Rev. Growth (YoY)Latest quarter vs prior year-2.5%+9.4%+17.2%+4.7%
EPS Growth (YoY)Latest quarter vs prior year-26.7%-76.1%+23.3%+46.2%
DSGX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ACMR leads this category, winning 3 of 7 comparable metrics.

At 38.4x trailing earnings, DSGX trades at a 87% valuation discount to IBTA's 305.9x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs DSGX's 1.50x — a lower PEG means you pay less per unit of expected earnings growth.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
Market CapShares × price$1.0B$3.9B$6.3B$2.5B
Enterprise ValueMkt cap + debt − cash$880M$3.5B$6.0B$2.6B
Trailing P/EPrice ÷ TTM EPS305.92x43.21x38.42x-46.25x
Forward P/EPrice ÷ next-FY EPS est.29.68x39.34x62.25x
PEG RatioP/E ÷ EPS growth rate1.22x1.50x
EV / EBITDAEnterprise value multiple88.24x27.49x18.10x
Price / SalesMarket cap ÷ Revenue3.04x4.35x8.47x2.61x
Price / BookPrice ÷ Book value/share3.84x2.06x3.99x3.67x
Price / FCFMarket cap ÷ FCF13.89x23.71x
ACMR leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

DSGX leads this category, winning 8 of 9 comparable metrics.

DSGX delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-8 for ICHR. DSGX carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICHR's 0.28x. On the Piotroski fundamental quality scale (0–9), DSGX scores 7/9 vs ACMR's 2/9, reflecting strong financial health.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
ROE (TTM)Return on equity-2.4%+6.1%+10.7%-7.5%
ROA (TTM)Return on assets-1.3%+3.9%+9.2%-5.2%
ROICReturn on invested capital+1.1%+7.0%+14.9%-3.9%
ROCEReturn on capital employed+0.4%+6.6%+15.6%-4.7%
Piotroski ScoreFundamental quality 0–95273
Debt / EquityFinancial leverage0.09x0.16x0.01x0.28x
Net DebtTotal debt minus cash-$161M-$463M-$346M$87M
Cash & Equiv.Liquid assets$187M$766M$354M$98M
Total DebtShort + long-term debt$26M$303M$8M$186M
Interest CoverageEBIT ÷ Interest expense20.44x229.22x-5.97x
DSGX leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ACMR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $3,555 for IBTA. Over the past 12 months, ICHR leads with a +329.1% total return vs DSGX's -31.7%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs IBTA's -29.2% — a key indicator of consistent wealth creation.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
YTD ReturnYear-to-date+60.3%+31.9%-13.8%+249.0%
1-Year ReturnPast 12 months-21.9%+195.6%-31.7%+329.1%
3-Year ReturnCumulative with dividends-64.4%+487.9%-5.1%+151.1%
5-Year ReturnCumulative with dividends-64.4%+133.4%+19.7%+28.9%
10-Year ReturnCumulative with dividends-64.4%+3065.8%+295.4%+629.1%
CAGR (3Y)Annualised 3-year return-29.2%+80.5%-1.7%+35.9%
ACMR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DSGX and ICHR each lead in 1 of 2 comparable metrics.

DSGX is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs IBTA's 58.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
Beta (5Y)Sensitivity to S&P 5001.10x3.24x0.71x3.93x
52-Week HighHighest price in past year$62.74$71.65$117.35$72.87
52-Week LowLowest price in past year$19.10$19.26$62.56$13.12
% of 52W HighCurrent price vs 52-week peak+58.5%+82.6%+62.5%+97.7%
RSI (14)Momentum oscillator 0–10074.160.747.766.9
Avg Volume (50D)Average daily shares traded270K1.2M583K795K
Evenly matched — DSGX and ICHR each lead in 1 of 2 comparable metrics.

Analyst Outlook

ACMR leads this category, winning 1 of 1 comparable metric.

Analyst consensus: IBTA as "Buy", ACMR as "Buy", DSGX as "Buy", ICHR as "Buy". Consensus price targets imply 121.7% upside for IBTA (target: $81) vs -32.4% for ACMR (target: $40). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.

MetricIBTA logoIBTAIbotta, Inc.ACMR logoACMRACM Research, Inc.DSGX logoDSGXThe Descartes Sys…ICHR logoICHRIchor Holdings, L…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$81.38$40.00$103.50$49.80
# AnalystsCovering analysts9101414
Dividend YieldAnnual dividend ÷ price+0.2%
Dividend StreakConsecutive years of raises31
Dividend / ShareAnnual DPS$0.11
Buyback YieldShare repurchases ÷ mkt cap+22.4%+0.2%+0.0%0.0%
ACMR leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ACMR leads in 3 of 6 categories (Valuation Metrics, Total Returns). DSGX leads in 2 (Income & Cash Flow, Profitability & Efficiency). 1 tied.

Best OverallACM Research, Inc. (ACMR)Leads 3 of 6 categories
Loading custom metrics...

IBTA vs ACMR vs DSGX vs ICHR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IBTA or ACMR or DSGX or ICHR a better buy right now?

For growth investors, ACM Research, Inc.

(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -6. 8% for Ibotta, Inc. (IBTA). The Descartes Systems Group Inc. (DSGX) offers the better valuation at 38. 4x trailing P/E (39. 3x forward), making it the more compelling value choice. Analysts rate Ibotta, Inc. (IBTA) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IBTA or ACMR or DSGX or ICHR?

On trailing P/E, The Descartes Systems Group Inc.

(DSGX) is the cheapest at 38. 4x versus Ibotta, Inc. at 305. 9x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus The Descartes Systems Group Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — IBTA or ACMR or DSGX or ICHR?

Over the past 5 years, ACM Research, Inc.

(ACMR) delivered a total return of +133. 4%, compared to -64. 4% for Ibotta, Inc. (IBTA). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus IBTA's -64. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IBTA or ACMR or DSGX or ICHR?

By beta (market sensitivity over 5 years), The Descartes Systems Group Inc.

(DSGX) is the lower-risk stock at 0. 71β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 454% more volatile than DSGX relative to the S&P 500. On balance sheet safety, The Descartes Systems Group Inc. (DSGX) carries a lower debt/equity ratio of 1% versus 28% for Ichor Holdings, Ltd. — giving it more financial flexibility in a downturn.

05

Which is growing faster — IBTA or ACMR or DSGX or ICHR?

By revenue growth (latest reported year), ACM Research, Inc.

(ACMR) is pulling ahead at 15. 2% versus -6. 8% for Ibotta, Inc. (IBTA). On earnings-per-share growth, the picture is similar: The Descartes Systems Group Inc. grew EPS 16. 5% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IBTA or ACMR or DSGX or ICHR?

The Descartes Systems Group Inc.

(DSGX) is the more profitable company, earning 22. 5% net margin versus -5. 6% for Ichor Holdings, Ltd. — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DSGX leads at 32. 3% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — IBTA leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IBTA or ACMR or DSGX or ICHR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus The Descartes Systems Group Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IBTA: 121. 7% to $81. 38.

08

Which pays a better dividend — IBTA or ACMR or DSGX or ICHR?

In this comparison, ACMR (0.

2% yield) pays a dividend. IBTA, DSGX, ICHR do not pay a meaningful dividend and should not be held primarily for income.

09

Is IBTA or ACMR or DSGX or ICHR better for a retirement portfolio?

For long-horizon retirement investors, The Descartes Systems Group Inc.

(DSGX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +295. 4% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DSGX: +295. 4%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IBTA and ACMR and DSGX and ICHR?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IBTA is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; DSGX is a small-cap quality compounder stock; ICHR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IBTA

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Gross Margin > 47%
Run This Screen
Stocks Like

ACMR

Steady Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

DSGX

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 13%
Run This Screen
Stocks Like

ICHR

Quality Business

  • Sector: Technology
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IBTA and ACMR and DSGX and ICHR on the metrics below

Revenue Growth>
%
(IBTA: -2.5% · ACMR: 9.4%)
P/E Ratio<
x
(IBTA: 305.9x · ACMR: 43.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.